• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Dominik Georg Haider, Karin Schindler, Georg Schaller, Gerhard Prager, Michael Wolzt, Bernhard Ludvik
  • Medicine
  • The Journal of clinical endocrinology and…
  • 2006 (First Publication: 1 April 2006)
  • CONTEXT The insulin-mimetic adipocytokine visfatin has been linked to obesity. The influence of weight loss on plasma visfatin concentrations in obese subjects is unknown yet. OBJECTIVES In thisContinue Reading
  • Sabine Steiner, Alexander Niessner, +9 authors Christoph W. Kopp
  • Medicine
  • Atherosclerosis
  • 2005 (First Publication: 1 August 2005)
  • OBJECTIVE As regular physical exercise improves endothelial dysfunction and promotes cardiovascular health, we investigated the effect of training on angiogenesis by measuring the number ofContinue Reading
  • Dennis Heutling, H. Schulz, +9 authors Hendrik Lehnert
  • Medicine
  • The Journal of clinical endocrinology and…
  • 2008
  • CONTEXT Insulin resistance plays a significant role in the pathogenesis of the polycystic ovary syndrome (PCOS) and represents a link to the unfavorable cardiovascular risk profile frequently foundContinue Reading
  • Dominik Georg Haider, Georg Schaller, Stylianos Kapiotis, Christina Maier, Anton Luger, Michael Wolzt
  • Biology, Chemistry, Medicine
  • Diabetologia
  • 2006 (First Publication: 1 August 2006)
  • Aims/hypothesisThe novel insulin-mimetic adipocytokine visfatin has been linked to the metabolic syndrome, but its regulation has not been characterised to date. Since insulin-mimetic actions ofContinue Reading
  • Katarzyna Krzyzanowska, Friedrich Mittermayer, Michael Wolzt, Guntram Schernthaner
  • Medicine
  • Diabetes Care
  • 2007 (First Publication: 1 July 2007)
  • OBJECTIVE— Circulating concentrations of an endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are elevated in patients with increased cardiovascular risk. WeContinue Reading